The company, Roche, has been in contact with NICE to request a delay to the submission deadline for this appraisal, due to regulatory feedback.
Therefore, the appraisal committee meeting discussion on 15 December 2021 has been cancelled. We will confirm the new timelines and update stakeholders when we have more information.